Filing Details
- Accession Number:
- 0001140361-13-035150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-05 18:51:34
- Reporting Period:
- 2013-09-04
- Filing Date:
- 2013-09-05
- Accepted Time:
- 2013-09-05 18:51:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238403 | K Daniel Spiegelman | 105 Digital Drive Novato CA 94949 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-04 | 9,000 | $39.06 | 46,950 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-04 | 9,000 | $69.00 | 37,950 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-09-04 | 9,000 | $0.00 | 9,000 | $39.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 88,000 | 2012-11-29 | 2022-05-28 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 plan executed on May 10, 2013.
- Option grant vests 6/48ths on November 29, 2012 and 1/48th on the 29th day of every month thereafter.
- Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
Billionaire Hedge Funds
